In a new case study, Synthego and Lonza discuss their recent collaboration with Dr. Manuel Albanese and exciting results in gene editing of resting human CD4+ T cells. This case study highlights how to achieve efficient gene editing in CD4+ T cells, overcoming the traditional challenges related to cell viability and maintaining resting state. The corresponding protocol guides you step-by-step through RNP and HDR template delivery in resting primary T cells with Nucleofection® Technology. Of note, further recommendations from Synthego and Lonza on how to adapt the protocol to other cell types and higher throughputs (e.g. 96-well format) are included in a tips and tricks section.
Download the protocol: CRISPR Editing Human Primary Resting CD4+ T Cells with RNPs using Nucleofector® Technology.
Commentaires
Enregistrer un commentaire
Thank you to leave a comment on my site